Add to ORKGFocus on Emerging Industries & Startups. The military has yet to test Nisin on anthrax bacteria, but ImmuCell\u27s stock has rapidly risen even above its previous successes treating human diarrhea and bovine sicknesses. Nisin is a broad-spectrum antibacterial, meaning it treats a large number of illnesses. Details
ImmuCell Corp. went public in 1987, and raised $5.5 million from investors for the creation and mark...
Nisin is a bacteriocin widely utilized in more than 50 countries as a safe and natural antibacterial...
Nisin is a 34 residue long cationic lanthionine antibiotic produced by Lactococcus lactis and antimi...
Nisin is a bacteriocin produced by a group of Gram-positive bacteria that belongs to Lactococcus and...
Nisin is a bacteriocin produced by Lactococcus lactis that has been approved by the Food Drug Admini...
Nisin is a lantibiotic (bacteriocin containing unusual amino acids) (Fig. 1) mainly produced by gram...
Antibiotic resistance and the shortage of novel antimicrobials are among the biggest chal-lenges fac...
The use of small antimicrobial peptides or bacteriocins, like nisin, to treat cancer is a new approa...
This report provides a background analysis of the market for nisin and other commercially available ...
Nisin A is the most thoroughly investigated member of the lantibiotic family of antimicrobial peptid...
<div><p>The use of small antimicrobial peptides or bacteriocins, like nisin, to treat cancer is a ne...
The use of small antimicrobial peptides or bacteriocins, like nisin, to treat cancer is a new approa...
Young biotech startups can benefit hugely from the US National Institutes of Health (NIH), not least...
Nisin is a bacteriocin widely utilized in more than 50 countries as a safe and natural antibacterial...
The emergence and dissemination of antibiotic resistant bacteria is a major medical challenge. Lanti...
ImmuCell Corp. went public in 1987, and raised $5.5 million from investors for the creation and mark...
Nisin is a bacteriocin widely utilized in more than 50 countries as a safe and natural antibacterial...
Nisin is a 34 residue long cationic lanthionine antibiotic produced by Lactococcus lactis and antimi...
Nisin is a bacteriocin produced by a group of Gram-positive bacteria that belongs to Lactococcus and...
Nisin is a bacteriocin produced by Lactococcus lactis that has been approved by the Food Drug Admini...
Nisin is a lantibiotic (bacteriocin containing unusual amino acids) (Fig. 1) mainly produced by gram...
Antibiotic resistance and the shortage of novel antimicrobials are among the biggest chal-lenges fac...
The use of small antimicrobial peptides or bacteriocins, like nisin, to treat cancer is a new approa...
This report provides a background analysis of the market for nisin and other commercially available ...
Nisin A is the most thoroughly investigated member of the lantibiotic family of antimicrobial peptid...
<div><p>The use of small antimicrobial peptides or bacteriocins, like nisin, to treat cancer is a ne...
The use of small antimicrobial peptides or bacteriocins, like nisin, to treat cancer is a new approa...
Young biotech startups can benefit hugely from the US National Institutes of Health (NIH), not least...
Nisin is a bacteriocin widely utilized in more than 50 countries as a safe and natural antibacterial...
The emergence and dissemination of antibiotic resistant bacteria is a major medical challenge. Lanti...
ImmuCell Corp. went public in 1987, and raised $5.5 million from investors for the creation and mark...
Nisin is a bacteriocin widely utilized in more than 50 countries as a safe and natural antibacterial...
Nisin is a 34 residue long cationic lanthionine antibiotic produced by Lactococcus lactis and antimi...